HLA-DRB1 and infection: If a wider study were to be conducted in which all individuals positive for SARS‐CoV‐2 RNA could be included, encompassing all ranges of clinical severity from mild symptoms to severe infection, it could be predicted that the increased frequency of HLA‐DRB1*10 and A*26 in individuals with the most clinically detrimental symptoms could take on greater significance.